The management selection and clinical outcomes in renal angiomyolipoma(report of 94 cases)

MO Cheng-qiang,MAO Xiao-peng,QIU Shao-peng,CHEN Jun-xing,CHEN Yu,LIN Huan-yi,ZHUANG Jin-tao
DOI: https://doi.org/10.3870/j.issn.1674-4624.2012.04.004
2012-01-01
Abstract:Objective To discuss the management of renal angiomyolipoma(RAML) and compare the clinical outcomes. Methods The data of 94 patients with RAML in recent 5 years was retrospectively reviewed,25 cases were male and 69 cases were female.The average age was 42 years old, and the average diameter was 6.6 cm. 73 cases were single RAML,21 cases were multiple tumors. Results 4 patients underwent emergent surgery due to bleeding from tumor rupture, 2 cases of nephrectomy, and 2 patients underwent selective arterial embolism(SAE) before nephron-sparing surgery(NSS).The other 90 patients had several different interventions, 71 for NSS, 13 for nephrectomy, 2 for SAE, and 4 for radiofrequency ablation(RFA). The operative and laparoscopic NSS have no significant difference in operation time, estimated blood loss and complication rates(P>0.05) for the patients with tumor diameter≤7 cm. However, the statistical difference was found in hospital days after surgery(P<0.05). Follow-up period was 3-48 monthes and no tumor metastasized or occurred again. Conclusions NSS, especially laparoscopic, is the first choice for surgical management of RAML, which shows the advantage of decurtation of hospital days. SAE is effective in controlling hemorrhage for RAML in the acute setting and also for the multiple or recurrence tumors.RFA is a new and effective nephron-sparing technology with the advantage of minimal invasion.
What problem does this paper attempt to address?